DrugPatentWatch Database Preview
LOSARTAN POTASSIUM Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Losartan Potassium, and when can generic versions of Losartan Potassium launch?
Losartan Potassium is a drug marketed by Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Cadista Pharms, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Prinston Inc, Sandoz, Strides Pharma, Teva, Torrent Pharms, Unichem Labs Ltd, Upsher Smith Labs, Watson Labs, Zydus Pharms Usa Inc, Apotex, and Teva Pharms. and is included in thirty-seven NDAs.
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for LOSARTAN POTASSIUM
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 37 |
| Suppliers / Packagers: | 48 |
| Bulk Api Vendors: | 197 |
| Clinical Trials: | 62 |
| Patent Applications: | 3,173 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LOSARTAN POTASSIUM |
| Drug Sales Revenues: | Drug sales revenues for LOSARTAN POTASSIUM |
| DailyMed Link: | LOSARTAN POTASSIUM at DailyMed |
See drug prices for LOSARTAN POTASSIUM
Recent Clinical Trials for LOSARTAN POTASSIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Steadman Philippon Research Institute | Phase 1/Phase 2 |
| Office of Naval Research (ONR) | Phase 1/Phase 2 |
| United States Department of Defense | Phase 1/Phase 2 |
Pharmacology for LOSARTAN POTASSIUM
| Drug Class | Angiotensin 2 Receptor Blocker |
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for LOSARTAN POTASSIUM
Paragraph IV (Patent) Challenges for LOSARTAN POTASSIUM
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| COZAAR | TABLET;ORAL | losartan potassium | 020386 |
US Patents and Regulatory Information for LOSARTAN POTASSIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 091629-003 | Jan 6, 2010 | AB | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Torrent Pharms | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 090528-003 | Apr 6, 2010 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sandoz | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 077424-002 | Oct 6, 2010 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
